More research is needed on insulin sensitizing therapies, including non-invasive lifestyle interventions, which could serve not only as add-ons for patients who experience anhedonia despite MDD treatment, but also for patients with addictions, chronic pain, and schizophrenia, or as a preventive strategy for healthy individuals who are prone to anhedonia. Here, INS is linked to schizophrenia.